As PURA Syndrome is described to result from a haploinsufficiency and thereby lowered cellular PURA levels, our findings on PURA-dependent, LSM14A/DDX6-mediated P-body formation could potentially relate to a molecular dysfunction in patients. This evidence concerns the gene PURA and PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation.